Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment

NCT00536172 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Depression

Interventions

DRUG: Escitalopram
DRUG: Placebo

Sponsor

University of Nebraska

Collaborators

[object Object]